Federal State Autonomous Institution N.N. Burdenko National Medical Research Center of Neurosurgery of the Ministry of Health of the Russian Federation, Moscow, Russian Federation.
Sci Rep. 2022 Feb 8;12(1):2121. doi: 10.1038/s41598-022-05992-4.
The aim of the study was to evaluate the role of pseudocontinuous arterial spin labeling perfusion (pCASL-perfusion) in preoperative assessment of cerebral glioma grades. The study group consisted of 253 patients, aged 7-78 years with supratentorial gliomas (65 low-grade gliomas (LGG), 188 high-grade gliomas (HGG)). We used 3D pCASL-perfusion for each patient in order to calculate the tumor blood flow (TBF). We obtained maximal tumor blood flow (maxTBF) in small regions of interest (30 ± 10 mm) and then normalized absolute maximum tumor blood flow (nTBF) to that of the contralateral normal-appearing white matter of the centrum semiovale. MaxTBF and nTBF values significantly differed between HGG and LGG groups (p < 0.001), as well as between patient groups separated by the grades (grade II vs. grade III) (p < 0.001). Moreover, we performed ROC-analysis which demonstrated high sensitivity and specificity in differentiating between HGG and LGG. We found significant differences for maxTBF and nTBF between grade III and IV gliomas, however, ROC-analysis showed low sensitivity and specificity. We did not observe a significant difference in TBF for astrocytomas and oligodendrogliomas. Our study demonstrates that 3D pCASL-perfusion as an effective diagnostic tool for preoperative differentiation of glioma grades.
本研究旨在评估伪连续动脉自旋标记灌注(pCASL-perfusion)在脑胶质瘤分级术前评估中的作用。研究组包括 253 名年龄在 7-78 岁的幕上胶质瘤患者(65 例低级别胶质瘤(LGG),188 例高级别胶质瘤(HGG))。我们对每位患者进行 3D pCASL-perfusion 以计算肿瘤血流(TBF)。我们在小感兴趣区(30±10mm)获得最大肿瘤血流(maxTBF),然后将绝对最大肿瘤血流(nTBF)归一化为大脑半卵圆中心对侧正常白质的血流量。HGG 和 LGG 组之间的 maxTBF 和 nTBF 值差异显著(p<0.001),以及按等级(二级与三级)分组的患者之间也有显著差异(p<0.001)。此外,我们进行了 ROC 分析,结果表明在区分 HGG 和 LGG 方面具有较高的敏感性和特异性。我们发现 maxTBF 和 nTBF 在 3 级和 4 级胶质瘤之间存在显著差异,但 ROC 分析显示敏感性和特异性较低。我们未观察到星形细胞瘤和少突胶质细胞瘤之间 TBF 有显著差异。我们的研究表明,3D pCASL-perfusion 是一种有效的术前胶质瘤分级诊断工具。